LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $239,000 | +78.4% | 32,093 | +66.6% | 0.02% | +27.8% |
| Q4 2016 | $134,000 | -15.7% | 19,262 | 0.0% | 0.02% | -14.3% |
| Q3 2016 | $159,000 | -84.9% | 19,262 | -85.2% | 0.02% | -84.9% |
| Q2 2016 | $1,055,000 | +50.9% | 130,196 | -5.4% | 0.14% | +65.5% |
| Q1 2016 | $699,000 | -1.7% | 137,583 | +49.3% | 0.08% | -5.6% |
| Q4 2015 | $711,000 | +81.4% | 92,131 | +35.2% | 0.09% | +67.9% |
| Q3 2015 | $392,000 | +1.6% | 68,139 | +61.9% | 0.05% | -19.7% |
| Q2 2015 | $386,000 | -19.6% | 42,100 | +6.3% | 0.07% | -48.4% |
| Q1 2015 | $480,000 | – | 39,600 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |